FDA Approval Sought for Daratumumab/Rd for Frontline Transplant-Ineligible Myeloma - OncLive

FDA Approval Sought for Daratumumab/Rd for Frontline Transplant-Ineligible Myeloma  OncLive

A supplemental Biologics License Application (sBLA) has been initiated with the FDA for daratumumab (Darzalex) for use in combination with lenalidomide ...